Recruiting Pulmonary Embolism Studies in Bloomfield
Visual-acoustic Intervention With Service Delivery In-person and Via Telepractice Trial
Children with speech sound disorder show diminished intelligibility in spoken communication and may thus be perceived as less capable than peers, with negative consequences for both socioemotional and...
Generalization With AI Navigation Using StaRt
Speech Sound Disorder (SSD) affects a significant portion of school-aged children, leading to social and emotional challenges that can persist into adolescence and adulthood. The number of productions...
About Pulmonary Embolism Clinical Trials in Bloomfield
Pulmonary embolism (PE) is a blockage of an artery in the lungs, usually caused by blood clots that travel from the deep veins of the legs. It can be life-threatening and requires immediate medical attention. Treatment includes anticoagulants and in severe cases, thrombolytic therapy.
There are currently 2 pulmonary embolism clinical trials recruiting participants in Bloomfield, CONNECTICUT. These studies are seeking a combined 152 participants. Research is being sponsored by New York University. Clinical trial participation is free and participants receive study-related medical care at no cost.
Pulmonary Embolism Clinical Trials in Bloomfield — FAQ
Are there pulmonary embolism clinical trials in Bloomfield?
Yes, there are 2 pulmonary embolism clinical trials currently recruiting in Bloomfield, CONNECTICUT. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Bloomfield?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Bloomfield research site will contact you about next steps.
Are clinical trials in Bloomfield free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Bloomfield studies also compensate for your time and travel.
What pulmonary embolism treatments are being tested?
The 2 active trials in Bloomfield are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary embolism.
Data updated March 2, 2026 from ClinicalTrials.gov